ADIAL PHARMACEUTICALS INC's ticker is ADIL and the CUSIP is 00688A106. A total of 15 filers reported holding ADIAL PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $42,339 | -40.5% | 203,358 | 0.0% | 0.00% | – |
| Q1 2023 | $71,175 | -30.9% | 203,358 | -57.5% | 0.00% | – |
| Q4 2022 | $102,958 | -52.3% | 478,875 | -22.4% | 0.00% | – |
| Q3 2022 | $216,000 | -72.7% | 616,855 | +4.4% | 0.00% | – |
| Q2 2022 | $792,000 | -33.3% | 590,852 | 0.0% | 0.00% | – |
| Q1 2022 | $1,187,000 | -25.6% | 590,852 | 0.0% | 0.00% | – |
| Q4 2021 | $1,595,000 | -37.5% | 590,852 | -0.6% | 0.00% | – |
| Q3 2021 | $2,550,000 | +70.9% | 594,443 | +1.6% | 0.00% | – |
| Q2 2021 | $1,492,000 | +186.9% | 585,035 | +172.4% | 0.00% | – |
| Q1 2021 | $520,000 | +55.2% | 214,797 | +9.1% | 0.00% | – |
| Q4 2020 | $335,000 | -23.7% | 196,797 | 0.0% | 0.00% | – |
| Q3 2020 | $439,000 | +11.7% | 196,797 | -30.4% | 0.00% | – |
| Q2 2020 | $393,000 | +6.8% | 282,909 | 0.0% | 0.00% | – |
| Q1 2020 | $368,000 | -46.0% | 282,909 | 0.0% | 0.00% | – |
| Q4 2019 | $682,000 | +60.8% | 282,909 | 0.0% | 0.00% | – |
| Q3 2019 | $424,000 | -14.2% | 282,909 | -3.7% | 0.00% | – |
| Q2 2019 | $494,000 | -52.6% | 293,908 | -3.2% | 0.00% | – |
| Q1 2019 | $1,042,000 | +421.0% | 303,708 | +679.1% | 0.00% | – |
| Q4 2018 | $200,000 | – | 38,982 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|